CareRx Corporation (TSX:CRRX)
Canada · Delayed Price · Currency is CAD 3.260
+0.002 (0.06%)
Sep 15, 2026, 3:28 PM EST
CareRx Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 207 | 240 | 128 | 96 | 131 | 249 | |
Market Cap Growth | 2.75% | 87.34% | 32.98% | -26.20% | -47.55% | 163.72% |
Enterprise Value | 274 | 306 | 208 | 194 | 250 | 343 |
Last Close Price | 3.26 | 3.78 | 2.01 | 1.57 | 2.50 | 5.56 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.78 | 9.19 | - | - | - | - |
Forward PE | 13.17 | 22.74 | 42.21 | 40.72 | 260.50 | 299.40 |
PS Ratio | 0.55 | 0.65 | 0.35 | 0.26 | 0.34 | 0.95 |
PB Ratio | 1.89 | 2.19 | 1.52 | 1.18 | 2.03 | 3.02 |
P/TBV Ratio | 22.63 | 22.63 | - | - | - | - |
P/FCF Ratio | 8.38 | 9.51 | 3.95 | 4.25 | 10.62 | 129.74 |
P/OCF Ratio | 6.83 | 7.79 | 3.37 | 3.52 | 5.84 | 34.23 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.73 | 0.83 | 0.57 | 0.52 | 0.66 | 1.31 |
EV/EBITDA Ratio | 9.72 | 12.00 | 9.45 | 8.48 | 11.50 | 20.22 |
EV/EBIT Ratio | 22.18 | 26.87 | 30.73 | 28.44 | 33.85 | 72.11 |
EV/FCF Ratio | 11.08 | 12.15 | 6.43 | 8.57 | 20.34 | 178.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.70 | 0.71 | 0.98 | 1.20 | 2.10 | 1.60 |
Debt / EBITDA Ratio | 2.71 | 2.64 | 3.20 | 3.68 | 4.97 | 6.61 |
Debt / FCF Ratio | 3.09 | 3.09 | 2.55 | 4.32 | 11.00 | 68.53 |
Net Debt / Equity Ratio | 0.61 | 0.59 | 0.87 | 1.11 | 1.66 | 1.16 |
Net Debt / EBITDA Ratio | 2.78 | 2.51 | 3.33 | 3.97 | 4.92 | 5.65 |
Net Debt / FCF Ratio | 2.70 | 2.54 | 2.27 | 4.01 | 8.69 | 49.95 |
Asset Turnover | 1.63 | 1.59 | 1.61 | 1.49 | 1.40 | 1.20 |
Inventory Turnover | 14.44 | 14.73 | 13.86 | 13.32 | 14.20 | 14.10 |
Quick Ratio | 0.70 | 0.74 | 0.67 | 0.69 | 1.03 | 1.39 |
Current Ratio | 1.08 | 1.06 | 0.99 | 1.05 | 1.40 | 1.80 |
Return on Equity (ROE) | 27.34% | 26.97% | -5.43% | -7.41% | -46.82% | -48.57% |
Return on Assets (ROA) | 3.34% | 3.06% | 1.86% | 1.72% | 1.69% | 1.35% |
Return on Capital Employed (ROCE) | 6.80% | 6.30% | 4.20% | 4.00% | 3.70% | 2.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 12.99% | 10.89% | -3.51% | -5.61% | -26.32% | -9.13% |
FCF Yield | 11.94% | 10.51% | 25.30% | 23.51% | 9.42% | 0.77% |
Dividend Yield | 2.52% | 1.06% | - | - | - | - |
Payout Ratio | 14.09% | 4.82% | - | - | - | - |
Buyback Yield / Dilution | -5.06% | -7.03% | -5.06% | -20.49% | -36.54% | -72.00% |
Total Shareholder Return | -2.54% | -5.97% | -5.06% | -20.49% | -36.54% | -72.00% |